Type 3 secretion system 1 of Salmonella typhimurium and its inhibitors: a novel strategy to combat salmonellosis

Author(s):  
Sajjad Hussain ◽  
Ping Ouyang ◽  
Yingkun Zhu ◽  
Abdul Khalique ◽  
Changliang He ◽  
...  
2012 ◽  
Vol 8 (12) ◽  
pp. e1003070 ◽  
Author(s):  
Andrew J. Grant ◽  
Fiona J. E. Morgan ◽  
Trevelyan J. McKinley ◽  
Gemma L. Foster ◽  
Duncan J. Maskell ◽  
...  

2017 ◽  
Vol 10 (479) ◽  
pp. eaal4501 ◽  
Author(s):  
Nicole J. De Nisco ◽  
Mohammed Kanchwala ◽  
Peng Li ◽  
Jessie Fernandez ◽  
Chao Xing ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (9) ◽  
pp. e0203698 ◽  
Author(s):  
Trina L. Westerman ◽  
Lydia Bogomolnaya ◽  
Helene L. Andrews-Polymenis ◽  
M. Katherine Sheats ◽  
Johanna R. Elfenbein

2021 ◽  
Vol 9 (1) ◽  
pp. 187
Author(s):  
Doron Teper ◽  
Sheo Shankar Pandey ◽  
Nian Wang

Bacteria of the genus Xanthomonas cause a wide variety of economically important diseases in most crops. The virulence of the majority of Xanthomonas spp. is dependent on secretion and translocation of effectors by the type 3 secretion system (T3SS) that is controlled by two master transcriptional regulators HrpG and HrpX. Since their discovery in the 1990s, the two regulators were the focal point of many studies aiming to decipher the regulatory network that controls pathogenicity in Xanthomonas bacteria. HrpG controls the expression of HrpX, which subsequently controls the expression of T3SS apparatus genes and effectors. The HrpG/HrpX regulon is activated in planta and subjected to tight metabolic and genetic regulation. In this review, we cover the advances made in understanding the regulatory networks that control and are controlled by the HrpG/HrpX regulon and their conservation between different Xanthomonas spp.


2018 ◽  
Vol 114 (3) ◽  
pp. 534a
Author(s):  
Julian Rocha ◽  
Charles Richardson ◽  
Mingxing Zhang ◽  
Andreas Diepold ◽  
Andreas Gahlmann

mBio ◽  
2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Sagi Huja ◽  
Yaara Oren ◽  
Eva Trost ◽  
Elzbieta Brzuszkiewicz ◽  
Dvora Biran ◽  
...  

ABSTRACTHere we present an extensive genomic and genetic analysis of Escherichia coli strains of serotype O78 that represent the major cause of avian colisepticemia, an invasive infection caused by avian pathogenicEscherichia coli(APEC) strains. It is associated with high mortality and morbidity, resulting in significant economic consequences for the poultry industry. To understand the genetic basis of the virulence of avian septicemic E. coli, we sequenced the entire genome of a clinical isolate of serotype O78—O78:H19 ST88 isolate 789 (O78-9)—and compared it with three publicly available APEC O78 sequences and one complete genome of APEC serotype O1 strain. Although there was a large variability in genome content between the APEC strains, several genes were conserved, which are potentially critical for colisepticemia. Some of these genes are present in multiple copies per genome or code for gene products with overlapping function, signifying their importance. A systematic deletion of each of these virulence-related genes identified three systems that are conserved in all septicemic strains examined and are critical for serum survival, a prerequisite for septicemia. These are the plasmid-encoded protein, the defective ETT2 (E. colitype 3 secretion system 2) type 3 secretion system ETT2sepsis, and iron uptake systems. Strain O78-9 is the only APEC O78 strain that also carried the regulon coding for yersiniabactin, the iron binding system of theYersiniahigh-pathogenicity island. Interestingly, this system is the only one that cannot be complemented by other iron uptake systems under iron limitation and in serum.IMPORTANCEAvian colisepticemia is a severe systemic disease of birds causing high morbidity and mortality and resulting in severe economic losses. The bacteria associated with avian colisepticemia are highly antibiotic resistant, making antibiotic treatment ineffective, and there is no effective vaccine due to the multitude of serotypes involved. To understand the disease and work out strategies to combat it, we performed an extensive genomic and genetic analysis of Escherichia coli strains of serotype O78, the major cause of the disease. We identified several potential virulence factors, conserved in all the colisepticemic strains examined, and determined their contribution to growth in serum, an absolute requirement for septicemia. These findings raise the possibility that specific vaccines or drugs can be developed against these critical virulence factors to help combat this economically important disease.


2018 ◽  
Vol 20 (1) ◽  
pp. 33-50 ◽  
Author(s):  
Valérian Meline ◽  
Wesley Delage ◽  
Chrystelle Brin ◽  
Camille Li-Marchetti ◽  
Daniel Sochard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document